First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention

Anaphylaxis During Cardiac Surgery: Implications for Clinicians

(2009) Jerrold H. Levy et al.   ANESTHESIA AND ANALGESIA

European Perspectives

(2008)   CIRCULATION

Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease

(2008) Mark Y. Chan et al.   CIRCULATION

Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes

(2008) A. Budaj et al.   EUROPEAN HEART JOURNAL

A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor

(2008) M. Y. CHAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bivalirudin during Primary PCI in Acute Myocardial Infarction

(2008) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE